Pharmaceuticals, Biotechnology and Life Sciences
Pfizer will acquire Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases, Pfizer said in a press release Monday.
Arena Pharmaceuticals has dosed first patients in a trial called ELEVATE UC 52, which is the first of two pivotal trials within the Phase 3 registrational program designated to test etrasimod 2 mg in subjects with moderately to severely active ulcerative colitis (UC).
Arena Pharmaceuticals ARNA), today announced that it will host a key opinion leader (KOL) event for investors focused on sphingosine-1-phosphate…